Immunologic biomarker changes in patients exposed to intravenous iodinated contrast material

Ann Allergy Asthma Immunol. 2021 Jul;127(1):135-136. doi: 10.1016/j.anai.2021.03.021. Epub 2021 Mar 27.

Authors

Ian T Mark¹, Daniel E Maddox², Robert J McDonald¹, David F Kallmes³, Jennifer S McDonald⁴

Affiliations

¹ Department of Radiology, Mayo Clinic, Rochester, Minnesota.
² Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
³ Department of Radiology, Mayo Clinic, Rochester, Minnesota; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota.
⁴ Department of Radiology, Mayo Clinic, Rochester, Minnesota. Electronic address: [email protected].

PMID: 33781935
DOI: 10.1016/j.anai.2021.03.021

No abstract available

Publication types

Letter

MeSH terms

Administration, Intravenous
Aged
Biomarkers / blood*
Biomarkers / chemistry
Biomarkers / urine*
Contrast Media / administration & dosage
Contrast Media / adverse effects*
Female
Humans
Iohexol / adverse effects
Iohexol / analogs & derivatives
Male
Middle Aged
Pilot Projects
Tomography, X-Ray Computed*

Substances

Biomarkers
Contrast Media
Iohexol
iopromide